• Evolent Health Inc EVH.N reported quarterly adjusted earnings of 6 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 34 cents. The mean expectation of fourteen analysts for the quarter was for earnings of 10 cents per share. Wall Street expected results to range from 1 cents to 17 cents per share.

• Revenue fell 24.4% to $483.65 million from a year ago; analysts expected $460.31 million.

• Evolent Health Inc's reported EPS for the quarter was a loss of 63 cents​.

• The company reported a quarterly loss of $72.25 million.

• Evolent Health Inc shares had risen by 10.3% this quarter and lost 7.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 31.7% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Evolent Health Inc is $15.00

This summary was machine generated from LSEG data May 9 at 12:12 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)